Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say

3 hours ago 2
Read Entire Article
  1. Homepage
  2. Finance
  3. Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say

Related

US Business Inventories Hold Steady, Reflecting Unchanged Consumer Demand

US Business Inventories Hold Steady, Reflecting Unchanged Co...

25 minutes ago 1
SRPT Alert: Kehoe Law Firm, P.C. Investigating Potential Securities Fraud Claims on Behalf of Investors of Sarepta Therapeutics, Inc

SRPT Alert: Kehoe Law Firm, P.C. Investigating Potential Sec...

25 minutes ago 1
Supernus stock rating reiterated as Piper Sandler questions Sage deal

Supernus stock rating reiterated as Piper Sandler questions ...

25 minutes ago 1

Trending

1. ticket master
2. sam rockwell
3. corvette
4. amsurg
5. al pacino
6. bbai stock
7. liberty university
8. run stock
9. amd stock price
10. enph stock

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

4 months ago 274
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

3 months ago 154
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

5 months ago 151
TOUS les JOURS Opens in Henderson!

TOUS les JOURS Opens in Henderson!

4 months ago 117
Sole mates: Find the perfect shoes for your fitness journey

Sole mates: Find the perfect shoes for your fitness journey

5 months ago 112
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved